Leukemia inhibitory factor

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:LIF Crystal Structure.rsh.png
Crystal structure of leukemia inhibitory factor (LIF)
leukemia inhibitory factor (cholinergic differentiation factor)
Identifiers
Symbol LIF
Entrez 3976
HUGO 6596
OMIM 159540
PDB 1lki
RefSeq NM_002309
UniProt P15018
Other data
Locus Chr. 22 q11.2-13.1

WikiDoc Resources for

Leukemia inhibitory factor

Articles

Most recent articles on Leukemia inhibitory factor

Most cited articles on Leukemia inhibitory factor

Review articles on Leukemia inhibitory factor

Articles on Leukemia inhibitory factor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Leukemia inhibitory factor

Images of Leukemia inhibitory factor

Photos of Leukemia inhibitory factor

Podcasts & MP3s on Leukemia inhibitory factor

Videos on Leukemia inhibitory factor

Evidence Based Medicine

Cochrane Collaboration on Leukemia inhibitory factor

Bandolier on Leukemia inhibitory factor

TRIP on Leukemia inhibitory factor

Clinical Trials

Ongoing Trials on Leukemia inhibitory factor at Clinical Trials.gov

Trial results on Leukemia inhibitory factor

Clinical Trials on Leukemia inhibitory factor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Leukemia inhibitory factor

NICE Guidance on Leukemia inhibitory factor

NHS PRODIGY Guidance

FDA on Leukemia inhibitory factor

CDC on Leukemia inhibitory factor

Books

Books on Leukemia inhibitory factor

News

Leukemia inhibitory factor in the news

Be alerted to news on Leukemia inhibitory factor

News trends on Leukemia inhibitory factor

Commentary

Blogs on Leukemia inhibitory factor

Definitions

Definitions of Leukemia inhibitory factor

Patient Resources / Community

Patient resources on Leukemia inhibitory factor

Discussion groups on Leukemia inhibitory factor

Patient Handouts on Leukemia inhibitory factor

Directions to Hospitals Treating Leukemia inhibitory factor

Risk calculators and risk factors for Leukemia inhibitory factor

Healthcare Provider Resources

Symptoms of Leukemia inhibitory factor

Causes & Risk Factors for Leukemia inhibitory factor

Diagnostic studies for Leukemia inhibitory factor

Treatment of Leukemia inhibitory factor

Continuing Medical Education (CME)

CME Programs on Leukemia inhibitory factor

International

Leukemia inhibitory factor en Espanol

Leukemia inhibitory factor en Francais

Business

Leukemia inhibitory factor in the Marketplace

Patents on Leukemia inhibitory factor

Experimental / Informatics

List of terms related to Leukemia inhibitory factor

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Leukemia inhibitory factor, or LIF, an interleukin 6 class cytokine, is a chemical in cells that affects their growth and development.

Function

LIF derives its name from its ability to induce the terminal differentiation of myeloid leukaemic cells. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.

Binding/activation

LIF binds to the specific LIF receptor (LIFR-α) which forms a heterodimer with a specific subunit common to all members of that family of receptors, the GP130 signal transducing subunit. This leads to activation of the JAK/STAT (Janus kinase/signal transducer and activator of transcription) and MAPK (mitogen activated protein kinase) cascades.

Expression

LIF is normally expressed in the trophectoderm of the developing embryo, with its receptor LIFR expressed throughout the inner cell mass. As embryonic stem cells are derived from the inner cell mass at the blastocyst stage, removing them from the inner cell mass also removes their source of LIF.

Use in stem cell culture

Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential. Therefore LIF is used in mouse embryonic stem cell culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for Lif independent growth, notably overexpression of the gene Nanog.

Lif is not required for culture of human embryonic stem cells.

External links


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
related articles